Development of an Optimized Protocol for NMR Metabolomics Studies of Human Colon Cancer Cell Lines and First Insight from Testing of the Protocol Using DNA G-Quadruplex Ligands as Novel Anti-Cancer Drugs.
about
Development of an Optimized Protocol for NMR Metabolomics Studies of Human Colon Cancer Cell Lines and First Insight from Testing of the Protocol Using DNA G-Quadruplex Ligands as Novel Anti-Cancer Drugs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of an Optimized Pr ...... ds as Novel Anti-Cancer Drugs.
@ast
Development of an Optimized Pr ...... ds as Novel Anti-Cancer Drugs.
@en
type
label
Development of an Optimized Pr ...... ds as Novel Anti-Cancer Drugs.
@ast
Development of an Optimized Pr ...... ds as Novel Anti-Cancer Drugs.
@en
prefLabel
Development of an Optimized Pr ...... ds as Novel Anti-Cancer Drugs.
@ast
Development of an Optimized Pr ...... ds as Novel Anti-Cancer Drugs.
@en
P2860
P50
P356
P1433
P1476
Development of an Optimized Pr ...... ds as Novel Anti-Cancer Drugs.
@en
P2093
Ilaria Lauri
Søren Balling Engelsen
P2860
P356
10.3390/METABO6010004
P50
P577
2016-01-15T00:00:00Z